Cochlear said they expect underlying profit to grow in the double digits.
👉 Background: Cochlear is the Australian-founded medical device company that manufactures and sells cochlear implants, the device that's surgically inserted to help with hearing. It owns more than 60% of the global market sharein cochlear and acoustic implants.
👉 What happened: During the COVID years, Cochlear took a bit of a hit because there were significantly fewer elective surgeries. But now, at Cochlear's annual meeting with shareholders, they said they expect underlying profit to grow in the double digits.
👉 What else: The Cochlear board's dividend policy has committed to paying out 70 per cent of their underlying profit. So the bigger the profit, the better the news for investors' hip pocket too.
💡A dividend policy explains how a company will distribute its dividends to its shareholders.
💡There are three different types of dividend polices:
💡For Cochlear, they've gone with the ride or die policy (ie #2). And this year, it seems to be a winner for investors.
Sign up for Flux and join 100,000 members of the Flux family